Constituït a la tardor del 2011 i format pels següents 10 experts de reconegut prestigi en el camp de l’oncologia, el Consell Científic Assessor del VHIO ajudarà sens dubte que el VHIO continuï duent a terme la seva missió de desenvolupar i promoure una investigació translacional d’excel·lència:

Carlos L. Arteaga, MD (Chair)

  • Donna S. Hall Chair in Breast Cancer
  • Professor of Medicine and Cancer Biology
  • Associate Director of Clinical Research, Vanderbilt-Ingram Cancer Center, Nashville, USA

René Bernards, PhD

  • Head of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Julio E. Celis, PhD

  • Scientific Director, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark

Andrés Cervantes, MD, PhD

  • Associate Professor of Medicine, Head of Section of the Hematology and Medical Oncology Department, University Hospital of Valencia, Valencia, Spain

Fortunato Ciardiello, MD, PhD

  • Full Professor of Medical Oncology, Head of Experimental Therapeutics, the Division of Medical Oncology, Seconda Universitá di Napoli, Naples, Italy.

Stanley B. Kaye, MD, FRCP, FRCR

  • Head of the Drug Development Unit and Head of the Section of Medicine, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK

Carlos López Otín, PhD

  • Professor, Department of Biochemistry and Molecular Biology, University of Oviedo, Spain

Richard Marais, PhD

  • Director, Paterson Institute for Cancer Research, Manchester, UK

Jorge Reis-Filho, MD, PhD

  • Professor, Team Leader, Breakthrough Breast Cancer Research Center, Institute of Cancer Research, London, UK

Jesús San Miguel Izquierdo, MD

  • Scientific Director, Salamanca Institute of Biomedical Research, Salamanca, Spain